Zydus Lifesciences Shows Strong Financial Performance Amid Market Challenges
Zydus Lifesciences has recently experienced a change in its valuation grade, reflecting strong financial performance. The company boasts a return on equity of 19.63% and a low debt-to-equity ratio. With significant growth in operating profit and consistent positive results over seven quarters, it demonstrates resilience in the competitive pharmaceuticals market.
Zydus Lifesciences, a prominent player in the Pharmaceuticals & Drugs industry, has recently undergone an adjustment in evaluation, reflecting a shift in its valuation grade. This revision highlights the company's financial metrics, which indicate a robust management efficiency, evidenced by a return on equity (ROE) of 19.63%. The company maintains a low debt-to-equity ratio, suggesting a stable financial structure.In terms of profitability, Zydus Lifesciences has reported significant growth in operating profit, with an annual growth rate of 22.23%. The latest quarter's results show a profit before tax (PBT) of Rs 1,126.90 crore, marking a growth of 30.13%, while the profit after tax (PAT) reached Rs 1,023.75 crore, reflecting a 32.5% increase. The company's price-to-book value stands at 3.97, and its PEG ratio is notably low at 0.56, indicating an attractive valuation relative to its earnings growth.
Despite facing challenges in the market, Zydus Lifesciences has consistently delivered positive results over the past seven quarters, showcasing its resilience in a competitive landscape.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
